Penelope A. Bradbury

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 108 publications

Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.

Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 13, 2026

Novel germline genetic variants associated with venous thrombo-embolism (VTE) and arterial thrombo-embolism (ATE) risk in patients with ALK and ROS1 fusion non-small cell lung cancer (NSCLC).

Novel germline genetic variants associated with venous thrombo-embolism (VTE) and arterial thrombo-embolism (ATE) risk in patients with ALK and ROS1 fusion non-small cell lung cancer (NSCLC).

Journal: Thrombosis research

Published: December 06, 2025

Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.

Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.

Journal: JTO clinical and research reports

Published: August 15, 2025

Weight, BSA, Toxicity, and Efficacy of Tyrosine Kinase Inhibitors for ALK-Mutated NSCLC.

Weight, BSA, Toxicity, and Efficacy of Tyrosine Kinase Inhibitors for ALK-Mutated NSCLC.

Journal: JTO clinical and research reports

Published: July 08, 2025

A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastases.

A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastases.

Journal: Therapeutic advances in medical oncology

Published: May 12, 2025

Retrospective cohort study assessing clinical outcomes of patients with extensive-stage small cell lung cancer treated with and without consolidative thoracic radiotherapy at the Princess Margaret Cancer Centre.

Retrospective cohort study assessing clinical outcomes of patients with extensive-stage small cell lung cancer treated with and without consolidative thoracic radiotherapy at the Princess Margaret Cancer Centre.

Journal: BMJ open

Published: March 21, 2025

Treatment of Pleural Mesothelioma: ASCO Guideline Update.

Treatment of Pleural Mesothelioma: ASCO Guideline Update.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 08, 2025

Informational Needs of Lung Cancer Patients and Caregivers.

Informational Needs of Lung Cancer Patients and Caregivers.

Journal: Journal of cancer education : the official journal of the American Association for Cancer Education

Published: December 19, 2024

Prognostic and predictive effects of TP53 co-mutation in patients with non-small cell lung cancer with rare treatable driver mutations.

Prognostic and predictive effects of TP53 co-mutation in patients with non-small cell lung cancer with rare treatable driver mutations.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 12, 2024

Real-World Creatinine-Based Estimates of Acute and Chronic Kidney Dysfunction in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase Inhibitors.

Real-World Creatinine-Based Estimates of Acute and Chronic Kidney Dysfunction in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase Inhibitors.

Journal: Clinical lung cancer

Published: September 18, 2024

Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors.

Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors.

Journal: JTO clinical and research reports

Published: September 13, 2024

Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations.

Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations.

Journal: Therapeutic advances in medical oncology

Published: September 01, 2024

Showing 1-12 of 108

Last Updated: 09/26/2026